Community-based screening for infantile anemia in an Okinawan village, Japan
MetadataShow full item record
Infancy is a vulnerable age group for anemia throughout the world. However, community-based screening for infantile anemia is seldom reported. This study determined the prevalence of anemia among infants in an Okinawan village from 2003 to 2008, in relation to secondary prevention of the condition. The prevalence among infants aged 3–5, 6–12 and 16–23 months was 12.3%, 15.8%, and 4.2%, respectively, based on cross-sectional surveys (n = 3070 ), and was 11.0%, 17.2%, and 3.9% according to another retrospective cohort study (n = 511 ). The relatively low prevalence of anemia at early childhood suggested that previous detection and treatment through early and late infantile screening had been successful.
This article is published under the Open Access publishing model and distributed under the terms of the Creative Commons License http://creativecommons.org/licenses/by/3.0/ Please refer to the licence to obtain terms for any further reuse or distribution of this work
Showing items related by title, author, creator and subject.
The epidemiology of anemia in pediatric inflammatory bowel disease: Prevalence and associated factors at diagnosis and follow-up and the impact of exclusive enteral nutritionGerasimidis, K.; Barclay, A.; Papangelou, A.; Missiou, D.; Buchanan, E.; Tracey, C.; Tayler, R.; Russell, R.; Edwards, Christine; McGrogan, P. (2013)Background: Anemia is poorly studied in pediatric inflammatory bowel disease. This study explored the epidemiology and associated factors of anemia at diagnosis, after 1 year, and during treatment with exclusive enteral ...
Hemoglobin and Change in Hemoglobin Status Predict Mortality, Cardiovascular Events, and Bleeding in Stable Coronary Artery DiseaseKalra, P.; Greenlaw, N.; Ferrari, R.; Ford, I.; Tardif, J.; Tendera, M.; Reid, Christopher; Danchin, N.; Stepinska, J.; Steg, P.; Fox, K. (2017)Background: Anemia is a predictor of adverse outcomes in acute myocardial infarction. We studied the relationship of hemoglobin, or its change over time, and outcomes in patients with stable coronary artery disease. ...
Dysregulated erythropoietin, hepcidin, and bone marrow iron metabolism contribute to interferon-induced anemia in hepatitis CVan Rijnsoever, M.; Galhenage, S.; Mollison, L.; Gummer, J.; Trengove, R.; Olynyk, John (2016)© Mary Ann Liebert, Inc.Anemia is a complication of interferon-containing hepatitis C treatments. We characterized effects of interferon-based therapy on hepcidin and erythropoietin (EPO) production, iron metabolism, ...